Insiders · ONTX

ONTX insider transactions

Onconova Therapeutics Inc. (ONTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ONTX

• 787d
  New insider Orbimed Advisors Llc claimed ownership of 1,045,261 shares (SEC Form 3) (Amendment)

  3/A - Traws Pharma, Inc. (0001130598) (Issuer)
• 788d
  New insider Tpav, Llc claimed ownership of 1,222,738 shares (SEC Form 3) (Amendment)

  3/A - Traws Pharma, Inc. (0001130598) (Issuer)
• 796d
  Redfield Robert was granted 97,500 shares (SEC Form 4)

  4 - Traws Pharma, Inc. (0001130598) (Issuer)
• 796d
  Pauza Charles David was granted 97,500 shares (SEC Form 4)

  4 - Traws Pharma, Inc. (0001130598) (Issuer)
• 796d
  Cautreels Werner was granted 200,000 shares (SEC Form 4)

  4 - Traws Pharma, Inc. (0001130598) (Issuer)
• 796d
  Savchuk Nikolay was granted 2,664,869 shares (SEC Form 4)

  4 - Traws Pharma, Inc. (0001130598) (Issuer)
• 796d
  Dukes Iain D. was granted 1,779,337 shares (SEC Form 4)

  4 - Traws Pharma, Inc. (0001130598) (Issuer)
• 796d
  New insider Viriom, Inc. claimed ownership of 1,645,100 shares (SEC Form 3)

  3 - Traws Pharma, Inc. (0001130598) (Issuer)
• 796d
  New insider Orbimed Advisors Llc claimed ownership of 885,532 shares (SEC Form 3)

  3 - Traws Pharma, Inc. (0001130598) (Issuer)
• 796d
  SEC Form 3 filed by new insider Redfield Robert

  3 - Traws Pharma, Inc. (0001130598) (Issuer)
• 796d
  SEC Form 3 filed by new insider Pauza Charles David

  3 - Traws Pharma, Inc. (0001130598) (Issuer)
• 796d
  SEC Form 3 filed by new insider Cautreels Werner

  3 - Traws Pharma, Inc. (0001130598) (Issuer)
• 796d
  New insider Tpav, Llc claimed ownership of 885,532 shares (SEC Form 3)

  3 - Traws Pharma, Inc. (0001130598) (Issuer)
• 796d
  SEC Form 3 filed by new insider Savchuk Nikolay

  3 - Traws Pharma, Inc. (0001130598) (Issuer)
• 796d
  SEC Form 3 filed by new insider Dukes Iain D.

  3 - Traws Pharma, Inc. (0001130598) (Issuer)
• 815d
  Guerin Mark Patrick converted options into 8,666 shares and covered exercise/tax liability with 2,591 shares, increasing direct ownership by 20% to 35,976 units (SEC Form 4)

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 815d
  Fruchtman Steven M converted options into 23,111 shares and covered exercise/tax liability with 8,727 shares, increasing direct ownership by 24% to 74,792 units (SEC Form 4)

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 850d
  Guerin Mark Patrick converted options into 6,900 shares and covered exercise/tax liability with 2,443 shares, increasing direct ownership by 18% to 29,901 units (SEC Form 4)

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 850d
  Fruchtman Steven M covered exercise/tax liability with 9,212 shares and converted options into 21,320 shares, increasing direct ownership by 25% to 60,408 units (SEC Form 4)

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1029d
  SEC Form 4 filed by Shoemaker Mary Teresa

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1029d
  SEC Form 4 filed by Stover Jack E

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1029d
  SEC Form 4 filed by Atadja Peter

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1029d
  SEC Form 4 filed by Clarke Trafford

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1029d
  SEC Form 4 filed by Mehta Viren

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1029d
  SEC Form 4 filed by Groopman Jerome

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1029d
  SEC Form 4 filed by Marino James J

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1039d
  SEC Form 4: Guerin Mark Patrick covered exercise/tax liability with 1,422 shares and converted options into 4,750 shares, increasing direct ownership by 15% to 25,444 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1039d
  SEC Form 4: Fruchtman Steven M converted options into 12,567 shares and covered exercise/tax liability with 4,744 shares, increasing direct ownership by 19% to 48,300 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1091d
  SEC Form 4 filed by Guerin Mark Patrick

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1182d
  SEC Form 4 filed by Guerin Mark Patrick

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1182d
  SEC Form 4 filed by Fruchtman Steven M

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1182d
  SEC Form 4 filed by Gelder Mark S. Md

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1216d
  SEC Form 4: Fruchtman Steven M covered exercise/tax liability with 6,977 shares and converted options into 21,320 shares, increasing direct ownership by 55% to 40,477 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1216d
  SEC Form 4: Gelder Mark S. Md converted options into 5,833 shares and covered exercise/tax liability with 1,242 shares, increasing direct ownership by 78% to 10,487 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1216d
  SEC Form 4: Guerin Mark Patrick converted options into 6,900 shares and covered exercise/tax liability with 1,785 shares, increasing direct ownership by 39% to 18,191 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1267d
  SEC Form 4 filed by Clarke Trafford

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1267d
  SEC Form 4 filed by Atadja Peter

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1267d
  SEC Form 3 filed by new insider Clarke Trafford

  3 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1267d
  SEC Form 3 filed by new insider Atadja Peter

  3 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1389d
  SEC Form 4 filed by Stover Jack E

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1389d
  SEC Form 4 filed by Marino James J

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1389d
  SEC Form 4 filed by Mehta Viren

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1389d
  SEC Form 4 filed by Shoemaker Mary Teresa

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1389d
  SEC Form 4 filed by Groopman Jerome

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1404d
  SEC Form 4: Guerin Mark Patrick converted options into 4,750 shares and covered exercise/tax liability with 1,355 shares, increasing direct ownership by 35% to 13,076 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1404d
  SEC Form 4: Gelder Mark S. Md converted options into 4,650 shares and covered exercise/tax liability with 1,135 shares, increasing direct ownership by 148% to 5,896 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1404d
  SEC Form 4: Fruchtman Steven M converted options into 12,566 shares and covered exercise/tax liability with 4,562 shares, increasing direct ownership by 44% to 26,134 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1456d
  SEC Form 4 filed by Guerin Mark Patrick

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1580d
  SEC Form 4 filed by Gelder Mark S. Md

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1580d
  SEC Form 4 filed by Fruchtman Steven M

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1580d
  SEC Form 4 filed by Oler Abraham N.

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1580d
  SEC Form 4 filed by Guerin Mark Patrick

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1589d
  SEC Form 4: Oler Abraham N. bought $2,505 worth of shares (1,500 units at $1.67), increasing direct ownership by 7% to 24,514 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1596d
  SEC Form 4: Oler Abraham N. bought $3,030 worth of shares (1,500 units at $2.02), increasing direct ownership by 7% to 23,014 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1602d
  SEC Form 4: Oler Abraham N. bought $3,300 worth of shares (1,500 units at $2.20), increasing direct ownership by 7% to 21,514 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1610d
  SEC Form 4: Oler Abraham N. bought $3,585 worth of shares (1,500 units at $2.39), increasing direct ownership by 8% to 20,014 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1658d
  SEC Form 4: Oler Abraham N. bought $3,160 worth of shares (1,000 units at $3.16), increasing direct ownership by 6% to 18,514 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1662d
  SEC Form 4: Oler Abraham N. exercised 5,000 in-the-money shares at a strike of $3.00, increasing direct ownership by 40% to 17,514 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1713d
  SEC Form 4: Oler Abraham N. bought $10,000 worth of shares (2,381 units at $4.20), increasing direct ownership by 23% to 12,515 units

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)
• 1713d
  SEC Form 4: Gelder Mark S. Md bought $10,000 worth of shares (2,381 units at $4.20)

  4 - Onconova Therapeutics, Inc. (0001130598) (Issuer)